NASDAQ
Oramed Pharmaceuticals Inc. (ORMP) has a current ratio of 6.98x as of Monday, May 25, 2026. This represents a 60.02% decrease compared to its 12-month average of 17.47x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.